ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,21
1,00%
Bitcoin
62 878,73
2,33%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BELLUS Health Inc (BLU)

  7. BELLUS Health Inc (BLU) Actualités

BLU

BELLUS Health (BLU)

BELLUS Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BLU
DateHeureSourceTitreSymboleSociété
30/01/202416h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUBELLUS Health Inc
14/08/202323h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUBELLUS Health Inc
10/07/202314h00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BLUBELLUS Health Inc
28/06/202323h22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
28/06/202323h21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
28/06/202322h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BLUBELLUS Health Inc
28/06/202322h10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:BLUBELLUS Health Inc
28/06/202320h42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
28/06/202317h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
28/06/202316h59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNASDAQ:BLUBELLUS Health Inc
28/06/202316h57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNASDAQ:BLUBELLUS Health Inc
16/06/202319h50Business WireBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersNASDAQ:BLUBELLUS Health Inc
16/06/202319h50Business WireBELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnairesNASDAQ:BLUBELLUS Health Inc
16/05/202323h01Business WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNASDAQ:BLUBELLUS Health Inc
16/05/202323h01Business WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNASDAQ:BLUBELLUS Health Inc
12/05/202322h01Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023NASDAQ:BLUBELLUS Health Inc
12/05/202322h01Business WireBELLUS Health Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
27/04/202300h00Business WireBELLUS Health Announces Meeting UpdatesNASDAQ:BLUBELLUS Health Inc
27/04/202300h00Business WireBELLUS Santé annonce de l’information récente au sujet de l’assembléeNASDAQ:BLUBELLUS Health Inc
18/04/202318h11Business WireGSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS HealthNASDAQ:BLUBELLUS Health Inc
18/04/202316h42Dow Jones NewsBellus Health Toronto-Listed Shares Double on GSK TakeoverNASDAQ:BLUBELLUS Health Inc
18/04/202312h30Dow Jones NewsTrending: GSK Buys Bellus Health for About $2 BillionNASDAQ:BLUBELLUS Health Inc
18/04/202312h24Dow Jones NewsBellus Health Shares Soar Premarket on Takeover by GSKNASDAQ:BLUBELLUS Health Inc
05/04/202313h00Business WireBELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release FormulationNASDAQ:BLUBELLUS Health Inc
05/04/202313h00Business WireBELLUS Santé annonce les résultats positifs de son étude d’équivalence de la biodisponibilité de phase 1 comparant la formule à libération prolongée et à dose quotidienne unique du camlipixant avec la formule à libération immédiate...NASDAQ:BLUBELLUS Health Inc
30/03/202322h06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BLUBELLUS Health Inc
23/03/202321h49Edgar (US Regulatory)Annual Report (foreign Private Issuer) (40-f)NASDAQ:BLUBELLUS Health Inc
21/03/202321h30Business WireBELLUS Health Reports Year 2022 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
21/03/202321h30Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice 2022NASDAQ:BLUBELLUS Health Inc
01/03/202313h00Business WireBELLUS Health to Participate in the Cowen 43rd Annual Health Care ConferenceNASDAQ:BLUBELLUS Health Inc
 Showing the most relevant articles for your search:NASDAQ:BLU

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
BN
Danone
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
EU
EN
Bouygues
NASDAQ
AMZN
Amazon.com
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés